Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an

A

admin

Administrator
Jun 17, 2007
66,216
0
36
49
Canada
Summary. This latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis - Drugs In Development, 2022, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape.New York, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update" - https://www.reportlinker.com/p06380633/?utm_source=GNW Multiple sclerosis
 
You must log in or register to reply here.

Similar threads

A
Global Endometriosis Drugs Market to Reach $3.3 Billion by 2030
Replies
0
Views
13
admin
A
A
Central Nervous System Drugs Market Research Report by Drug Classes, Diseases, Region
Replies
0
Views
15
admin
A
A
Global Product Design and Development Services Market to Reach $18.9 Billion by 2027
Replies
0
Views
18
admin
A
A
The Global Hospitality Robots Market is forecast to grow by USD 341.91 mn during 2022
Replies
0
Views
35
admin
A
A
The Global Kidney Stones Therapeutic Market is forecast to grow by USD 566.78 million
Replies
0
Views
24
admin
A
Back
Top